FDA
label_change
· 2012-03-13
FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application for ZYRTEC HIVES to expand cetirizine hydrochloride labeling to include treatment of hives (urticaria).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)